Konstantinopoulos, P. A., Costa, A. A. B. A. d., Gulhan, D., Lee, E. K., Cheng, S., Hendrickson, A. E. W., . . . Shapiro, G. I. (2021). A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.
Cita MLA (8a ed.)Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.